# MS DCF Valuation — Investment Banking Valuation Memo
**Date: 2026-08-10 (Monday morning ET, using state.md's 8/10 ~09:44 ET Robinhood-verified check-in) — NVDA/OMCL mechanical price rolls (models unchanged); XLE composite update on a further oil-price move, with a serious new data-quality flag: the underlying XOM/CVX quotes now move in the *opposite* direction from both oil and the live XLE tape; VTI/VXUS unchanged**

*Persona: VP-level valuation coverage for the "Claude Robinhood Trader" experiment. Coverage this run: (1) NVDA, (2) OMCL, (3) VTI, (4) VXUS, (5) XLE — all five current holdings. GS's current #1 pick (analysts/gs-stock-screener.md, 8/10 Monday-morning report) is again **OMCL**, already in-scope as a holding — no new name to add under this desk's self-feeding mandate this cycle. (Note for the record, outside this desk's mandate: GS's #2 this run is GEHC, promoted on a fresh Vital Diagnostics catalyst, with an explicit ask that MS/BW clear that rule-6 gate next — flagging it here since GS raised it directly, but this desk's coverage rule is holdings + #1 pick only, and #1 is unchanged.) All live holding prices below are the trader's own Robinhood-verified quotes from state.md's 8/10 ~09:44 ET check-in (first and, as of this writing, only run of the day — rule 4: never size off WebSearch for these five names); this desk has no direct Robinhood feed.*

---

## Verdicts (top line)

| Ticker | Current Price (8/10, ~09:44 ET) | DCF Fair Value (base case) | Verdict |
|---|---|---|---|
| **NVDA** | $222.99 (-0.43% vs Friday's $223.96 close) | ~$150.6 (WACC 11%, g 3%) — unchanged model | **OVERVALUED — ~32.5% downside to DCF fair value.** Essentially flat vs. 8/7's ~32.2%; a pure price-move effect, no model change. |
| **OMCL** | $37.235 (+1.15%, extending to a likely fourth straight up session) | ~$53.89 (WACC 9%, g 3%), unchanged | **UNDERVALUED — ~44.7% upside to DCF fair value.** Still the widest discount on the book, but narrowed from 8/7's ~48.0% as OMCL's rally continues — a price effect, not a model change. |
| **VTI** | $381.685 (-0.02%) | N/A — no single-company DCF applies | **NOT APPLICABLE / HOLD BY CONSTRUCTION.** Unchanged. Pool weight ~32.69%, still inside BR's 5pp drift band post the 8/7 trim. |
| **VXUS** | $86.84 (-0.42%) | N/A — no single-company DCF applies | **NOT APPLICABLE / HOLD BY CONSTRUCTION.** Unchanged. |
| **XLE** | $58.995 (+2.60%, day's leader) | Composite (oil-adjusted) fair value ≈ $49-50/sh, **low confidence — see flag below** | **STILL OVERVALUED, gap nominally ~16%** — but this cycle's underlying XOM/CVX inputs actively contradict both the oil move and XLE's own live tape; **treat the number as unreliable, not just narrowed.** **Do not add.** |

**Bottom line for the trader:** No verdict flips. NVDA and OMCL are mechanical price rolls against unchanged models — NVDA's gap is flat, OMCL's discount narrowed slightly as its rally continues (still the book's widest, still no sizing green light from this desk's chair). XLE is where this desk has a real problem to flag: today's live Robinhood quote has XLE up **+2.60%** on a genuine geopolitical catalyst (a missile strike on an ADNOC tanker in the Strait over the weekend, per GS's 8/10 report, plus Iran's harder reopening conditions), and WTI itself is confirmed up **+1.43%** to ~$79.30 — both consistent with a "hedge working as designed" day. But this cycle's WebSearch pull for XOM and CVX came back **down** 1.16% and 1.41% respectively. Two of the three inputs to this desk's composite (oil, XLE) point the same direction; the third (the underlying majors' equity quotes) points the opposite way, on the same day, without a company-specific reason found. That is a materially worse data-quality problem than the prior two cycles' "identical to the cent" staleness — this isn't stale, it's *inconsistent*. This desk is publishing the mechanical math below for completeness but is explicitly not certifying the resulting ~16% gap number, and the do-not-add stance rests on the qualitative case (XLE overvalued under essentially any plausible combination of these inputs), not on this specific number.

---

## 1. NVIDIA (NVDA) — price update, model unchanged

### What changed since 8/7
Price effectively flat: $222.99 (8/10, ~09:44 ET) vs. $222.195 (8/7 read), -0.43% against Friday's actual close of $223.96. Fresh WebSearch this morning surfaces nothing that changes the model: a $3B planned investment in Lancium (a Blackstone-backed data-center developer) and Zayo's 8,000+-mile fiber buildout using NVIDIA AI infrastructure — both ecosystem-expansion data points already in the same category as prior cycles' SpaceX/Starmind items, not new cash-flow inputs. State.md's own weekend sweep (SpaceX ~$2B chip commitment, an AMD AI-acquisition read as ecosystem-validating) is the same character of news — bullish sentiment, not a fundamentals input.

### Why the 5-year model still doesn't move
No new information since 8/7 changes any of the five build inputs (FY2027E revenue, FCF margin path, WACC, terminal growth, or the Starmind treatment). NVDA's Q2 FY2027 print (August 26) remains the next scheduled point at which this desk will revisit the model itself, not just the price.

### Verdict: **OVERVALUED, gap essentially flat**
Same 5-year build (FY2027E revenue $380B, FCF margin path 56%→48%, WACC 11% base, g 3% base):

| WACC \ Terminal g | 2.0% | 3.0% | 4.0% |
|---|---|---|---|
| **11% (base)** | $137.8 | **$150.6** | $167.1 |

Base case ($150.6) vs. today's $222.99 implies **~32.5% downside**, essentially unchanged from 8/7's ~32.2% (a rounding-level price drift, not a new read). Key breakable assumptions unchanged (margin durability is the upside break; China export policy, Blackwell-Rubin execution, HBM supply bottleneck, custom-silicon competition, and the OpenAI-financing/circularity thread remain the downside breaks; Starmind's eventual disclosed economics is the ongoing optionality watch item). **Hold, no add.** State.md's 8/10 ~09:44 ET check-in logs NVDA at ~12.42% of equity / ~10.95% of pool — comfortably below the 18-20% trigger; BR's flagged ~-4pp pool-basis underweight (a price-drift artifact, not a sizing signal) doesn't change this desk's read.

---

## 2. Omnicell (OMCL) — price update, model unchanged

### What changed since 8/7
Price up to $37.235 (8/10, ~09:44 ET) from $36.40 (8/7 read), +2.3% — state.md notes this extends what looks like a fourth straight up session, with no company-specific catalyst identified via WebSearch either this run or last. Fresh WebSearch this cycle confirms the same facts already in this desk's model — Q2 beat (EPS $0.94 vs. ~$0.44 est., revenue $312.2M, +7.4% YoY), the soft Q3 revenue guide (~$304M, ~2.9% below estimate) that triggered the post-print selloff, OMCL still down 18.3% YTD and ~28.3% below its 52-week high ($51.39), next print confirmed 10/29/26. Nothing new — this looks like continued technical mean-reversion off the post-earnings gap-down, not a fresh fundamental development.

### Fair value and verdict (model unchanged, gap recomputed vs. today's price)
Base case fair value **$53.89** (WACC 9%, g 3% — sensitivity table unchanged since 7/30) vs. today's live price **$37.235** implies **~44.7% upside**, narrowed from 8/7's ~48.0% — a pure price-drift effect (the stock rallying toward fair value), not a fresh data point on either side.

### Verdict: **UNDERVALUED — still the widest discount on the book**
This desk's job is valuation, not sizing. GS's 8/10 report again has OMCL at #1 (a seventh straight week unchanged) and is explicit that the sizing gate — a fresh post-transcript BW risk sign-off — is now the single longest-open process item on the whole board, ahead of both GEHC and IONQ. Nothing for this desk to add fundamentally until a fresh transcript-level development, that sign-off, or the 10/29 print. Worth flagging plainly: if the rally continues at this pace, the discount will keep compressing on price alone even though nothing about the underlying case has changed — the gate, not the gap, remains the binding constraint.

### Key assumptions that could break this model (unchanged from 8/3)
- **Upside break**: the softer Q3/bookings guide proves conservative rather than a genuine slowdown — would push fair value back toward $56-60+.
- **Downside break**: the bookings-range widening at the low end proves to be the first sign of a genuine demand slowdown as the platform-refresh cycle plays out — would require trimming FY27+ growth further.

---

## 3. Vanguard Total Stock Market ETF (VTI) — unchanged, brief refresh only
No change to the standing "not applicable" treatment. Price $381.685 (8/10, ~09:44 ET), -0.02%, essentially flat. Pool weight ~32.69% per state.md, +2.69pp over BR's 30% target but inside the 5pp drift band post the 8/7 $2.00 trim — no fresh drift-trigger action pending. This desk has no fair-value view on VTI and defers entirely to BR/BW on sizing.

## 4. Vanguard Total International Stock ETF (VXUS) — unchanged, brief refresh only
No change to the standing "not applicable" treatment. Price $86.84 (8/10, ~09:44 ET), -0.42%. Pool weight ~26.55%, +1.55pp over target, inside band. No DCF-based case to add or trim.

---

## 5. Energy Select Sector SPDR (XLE) — oil-adjusted update, with a worse data-quality flag than any prior cycle

### Data-quality flag — read this before the numbers below
This cycle's fresh WebSearch pull: **XOM $153.04 (-1.16%)**, **CVX $186.56 (-1.41%)**. On the surface these look like clean, non-stale figures — unlike 8/7's "identical to the cent" repeat, both numbers moved from the prior report ($154.85 → $153.04; $186.86 → $186.56). But the direction is the problem: today's WTI is confirmed up +1.43% to ~$79.30 (Fortune, TradingEconomics — corroborated across two sources and matching state.md's own live sweep), and XLE itself — the ETF whose ~35% AUM look-through this desk's composite is built on — is Robinhood-verified **up 2.60%**, the day's leader across the whole five-holding book, on a genuine weekend catalyst (a missile strike on an ADNOC tanker transiting Hormuz, per GS's 8/10 report). An ETF up 2.6% on a day its two largest weighted holdings are reportedly down over 1% each, while the commodity underlying both is also up, is not internally consistent. No XOM- or CVX-specific negative catalyst was found via WebSearch to explain a genuine divergence from the sector/commodity move. This desk's working theory (unverified): the WebSearch quotes for XOM/CVX are being pulled from a different intraday snapshot than the live Robinhood XLE and Fortune/TradingEconomics oil reads — a timing mismatch rather than a data-source error — but this desk cannot confirm that without a second, independently-timestamped source, which isn't available this cycle either.

### Oil-adjusted fair value update (mechanical, low-confidence)
Using 8/7's oil-adjusted fair values as the roll-forward base (XOM $104.79, CVX $193.84, built off a WTI input of $78.32) and applying the same ~1.2x earnings-sensitivity multiplier to today's further WTI increase (~$78.32 → ~$79.30, +1.25%, i.e. a further +~1.5% fair-value adjustment):

| | XOM | CVX |
|---|---|---|
| 8/7 fair value (oil-adjusted) | $104.79 | $193.84 |
| Further oil adjustment (+~1.5%, from +1.25% WTI move × 1.2x sensitivity) | +$1.57 | +$2.91 |
| **8/10 fair value (mechanical roll)** | **~$106.36** | **~$196.75** |
| Current price (8/10, WebSearch — **flagged as directionally inconsistent, see above**) | $153.04 | $186.56 |
| **Implied gap** | **-30.5% (overvalued)** | **+5.5% (modestly undervalued)** |

Blended composite gap (weighted ~59.6% XOM / ~40.4% CVX, per the standing ~35% AUM look-through split): **weighted gap ≈ -16.0%**, nominally narrower than 8/7's **-17.8%**. Applied to today's live XLE spot ($58.995, Robinhood-verified per state.md): implied fair value roughly **$49-50/sh**.

### Verdict: **STILL OVERVALUED — but don't lean on this specific number**
The qualitative case is robust regardless of which side of this cycle's data conflict is right: if the WebSearch XOM/CVX prices are accurate, XOM alone is ~30% overvalued and dominates the blend; if instead the underlying majors actually tracked oil and XLE upward today (the more internally-consistent story, and the one this desk's working theory favors), the composite gap would be *wider*, not narrower, since XLE's own price rose 2.6% while the fair-value inputs only moved ~1.5%. Either way, nothing in today's data supports narrowing the do-not-add stance. **No trim (rule 1 — no structural break, XLE is a small half-size position), no add.**

### Key assumptions that could break this model
- **Data-quality note (escalated again from 8/7)**: this is now a third consecutive session with an unresolved XOM/CVX quote problem — 8/6 and 8/7 were stale/repeated figures, today's is a fresh-looking but directionally-inconsistent pair. Per the standing note from 8/7, the next cycle should force a single-source, explicitly-timestamped XOM/CVX pull (e.g., query a specific finance-data provider directly, or cross-check against a second independent source in the same run) rather than accept either a repeat or an unexplained divergence a third time running.
- **Upside break**: an actual *signed* Hormuz reopening deal that sustainably lifts oil back toward or above GS's $80 Q4'26 house forecast would reverse today's adjustment — though today's news (a tanker missile strike, harder Iranian reopening conditions) points the opposite direction.
- **Downside break**: if today's XOM/CVX weakness turns out to be the real signal (e.g., a fresh company-specific or sector-rotation story this desk's WebSearch missed) and XLE's own +2.6% print instead proves to be the outlier, the gap could be meaningfully wider than the ~16% shown here.

---

## Cross-check with GS screener (analysts/gs-stock-screener.md, 2026-08-10 Monday morning)
GS again has OMCL at #1 (seventh week unchanged) and is explicit that the sizing gate is now the longest-open process item on the board, ahead of GEHC (promoted to #2 this run on a fresh Vital Diagnostics catalyst) and IONQ (downgraded to #5 after a weekend Wolfpack Research short-seller report attacking the DARPA-contract revenue narrative this desk has not evaluated — outside this cycle's mandate, flagged for the record only). GS's #4 read on XLE independently confirms today's +2.60% move as "the day's leader" on the same Hormuz-escalation driver this desk used above, and frames it as BW's hedge-decoupling thesis validated in the other direction — consistent with this desk's own read that XLE's move is directionally genuine even where the underlying-majors quotes this cycle are suspect. GS also reiterates the OXY rule-3 veto given the weekend tanker strike — consistent with this desk's own oil-adjusted work needing a real signed deal, not headline language, before any of that read changes.

## Explicit read on trader's current positions (all five: NVDA, OMCL, VTI, VXUS, XLE)
**NVDA**: hold, no add — DCF does not support adding at $222.99 (~32.5% downside to base case), the widest overvaluation gap on the book. Model itself unchanged pending the August 26 print.
**OMCL**: hold, no add from this desk's chair (sizing isn't this desk's call) — DCF discount now ~44.7%, still the widest gap on the book though narrowing as the rally continues. The BW post-transcript sign-off remains the binding constraint, now a seventh week open per GS.
**VTI / VXUS**: hold, no valuation view — diversified core-sleeve holdings, not DCF calls. Both inside BR's drift band post the 8/7 VTI trim.
**XLE**: hold, no trim, no add — do-not-add stance holds, and holds more firmly than a "narrower gap" headline would suggest, given this cycle's genuinely inconsistent XOM/CVX data (down) versus oil and XLE itself (both up). The qualitative case doesn't depend on resolving which side is right.

---

Sources:
- [NVDA: NVIDIA Corp - Stock Price, Quote and News (CNBC)](https://www.cnbc.com/quotes/NVDA)
- [History Says This Is What Will Happen to Nvidia Stock After Aug. 26 (Motley Fool)](https://www.fool.com/investing/2026/08/06/history-says-this-is-what-will-happen-to-nvidia-st/)
- [NVIDIA: NVDA Stock Price Quote & News (Robinhood)](https://robinhood.com/us/en/stocks/NVDA/)
- [First Week of August 2026 Options Trading For Omnicell (OMCL) (Nasdaq)](https://www.nasdaq.com/articles/first-week-august-2026-options-trading-omnicell-omcl)
- [Omnicell (OMCL) Research Report (StockStory)](https://stockstory.org/us/stocks/nasdaq/omcl)
- [Omnicell (OMCL) Stock Trades Down, Here Is Why (FinancialContent/StockStory)](https://markets.financialcontent.com/stocks/article/stockstory-2026-7-30-omnicell-omcl-stock-trades-down-here-is-why)
- [ExxonMobil Holdings (XOM) Stock Price & Overview (stockanalysis.com)](https://stockanalysis.com/stocks/xom/)
- [Chevron (CVX) Stock Price & Overview (stockanalysis.com)](https://stockanalysis.com/stocks/cvx/)
- [Check out XOM, CVX's stock price in real time (CNBC)](https://www.cnbc.com/quotes/xom,cvx)
- [Current price of oil as of August 10, 2026 (Fortune)](https://fortune.com/article/price-of-oil-08-10-2026/)
- [Crude Oil - Price - Chart - Historical Data (TradingEconomics)](https://tradingeconomics.com/commodity/crude-oil)
- Internal: trading-experiment/state.md (8/10 ~09:44 ET run notes, live Robinhood quotes), analysts/gs-stock-screener.md (8/10 Monday morning), analysts/bw-risk-assessment.md (8/7 ~14:41 ET, prior cycle), analysts/jpm-earnings-analyzer.md (8/10, ~market open), analysts/br-portfolio-builder.md (8/7 evening, prior cycle), analysts/ms-dcf-valuation.md (8/7, this desk's prior report, via git history)
